U.S. Antimony reported Q2 sales well below the average Wall Street target, prompting a large cut to its full-year sales guidance. The substantial guidance reduction signals a materially weaker demand outlook versus expectations.
U.S. Antimony reported Q2 sales well below the average Wall Street target, prompting a large cut to its full-year sales guidance. The substantial guidance reduction signals a materially weaker demand outlook versus expectations.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly negative
Sentiment Score
-0.55
Ticker Sentiment
